Related Experiment Video
Updated: Jun 12, 2026
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Evaluating older patients with diabetes for insulin pump therapy
Elizabeth A Stephens1, John Heffner
1Department of Medical Education, Oregon Health & Science University, Portland, OR 97213, USA. Elizabeth.Stephens@providence.org
Diabetes Technology & Therapeutics
|June 3, 2010
Summary
Insulin pumps may offer benefits for older adults with diabetes, but careful assessment of cognitive and motor skills is crucial for safe and effective use. Addressing age-related barriers ensures successful diabetes self-management in geriatric patients.
Area of Science:
- Geriatric Medicine
- Endocrinology
- Diabetes Management
Background:
- Diabetes prevalence is rising in elderly populations, necessitating tailored self-management strategies.
- Aging is associated with cognitive and motor skill decline, impacting treatment adherence.
- Insulin pump therapy is of interest for geriatric patients seeking improved glycemic control.
Purpose of the Study:
- To evaluate the effectiveness, safety, and feasibility of insulin pump therapy in older adults.
- To identify indications for insulin pump use in geriatric patients.
- To recognize age-related barriers to insulin pump therapy in the elderly.
Main Methods:
- Comparative analysis of insulin pump therapy versus traditional injected insulin.
- Assessment of patient cognitive and motor skills.
- Evaluation of glycemic control, safety, and feasibility in older age groups.
Main Results:
- Few studies have investigated insulin pump use in geriatric populations.
- Indications include glucose variability, hypoglycemia, and poor glycemic control.
- Barriers include visual, dexterity, and cognitive impairments.
Conclusions:
- Successful insulin pump implementation in older adults requires individualized assessment.
- An experienced diabetes management team is essential for tailoring therapy.
- Addressing age-related disabilities is key for effective diabetes self-management in the elderly.
Related Concept Videos
01:16Insulin: Dosing Regimen and Adverse Effects
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
01:27Insulin Formulations: Types and Delivery
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into rapid-acting...
Short-acting insulins are divided into rapid-acting...
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...